Vienna - Delayed Quote EUR
UCB SA (UCB.VI)
145.30
-0.75
(-0.51%)
As of 1:00:21 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
1,242,000
1,242,000
761,000
1,119,000
1,553,000
Investing Cash Flow
282,000
282,000
-440,000
-1,580,000
-487,000
Financing Cash Flow
-818,000
-818,000
-308,000
70,000
-1,119,000
End Cash Position
1,573,000
1,573,000
861,000
859,000
1,244,000
Capital Expenditure
-322,000
-322,000
-316,000
-371,000
-493,000
Issuance of Debt
572,000
572,000
597,000
1,025,000
--
Repayment of Debt
-756,000
-756,000
-424,000
-546,000
-716,000
Repurchase of Capital Stock
-162,000
-162,000
-40,000
-42,000
-60,000
Free Cash Flow
920,000
920,000
445,000
748,000
1,060,000
12/31/2021 - 2/13/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4587.T PeptiDream Inc.
1,931.00
+2.69%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
BIOCON.NS Biocon Limited
326.75
-2.67%
9926.HK Akeso, Inc.
100.000
+7.64%
GUBRA.CO Gubra A/S
353.40
-2.16%
FTRE Fortrea Holdings Inc.
5.32
-3.27%
2269.HK WuXi Biologics (Cayman) Inc.
22.850
+0.66%
DBVT DBV Technologies S.A.
9.26
+5.83%
MLTX MoonLake Immunotherapeutics
39.51
+0.15%
LEGN Legend Biotech Corporation
34.30
-0.52%